VitaVitro Biotech
韦拓生物
VitaVitro Biotech (韦拓生物) is an assisted-reproduction technology company that Dalton Venture has backed and led. Per Dalton's account, it is China's first and still only domestic player to have secured all seven required product registrations in its field, and it had already entered commercialization as of mid-2023 . Dalton led its Series B round, which positioned the company as an international supplier in assisted reproductive technology (ART) .
elsewhere's corpus does not cover this subject in depth — the only direct material comes from Dalton Venture's own publications on its portfolio. No independent elsewhere reporting or other partner pieces on VitaVitro's founding date, team, or financials appear in the bundle.
AI-generated — may contain errors, please verify.
Coverage
Steady Steps Toward Renewal, Momentum Into Waves | DTX 2025 Annual Review
Those who walk deeper into the cycle always spot the next beam of light.
Steadfast Progress, Grounded in Action | Dalton Venture's 2024 Year in Review
Looking back at 2024, "adjustment" and "patience" became the defining keywords for venture capital. Yet on the long-distance track of life sciences and medtech, Dalton Venture kept moving forward with steady, deliberate strides. We navigated market fluctuations, caught glimpses of innovation, and helped companies take root and grow through the cycles — writing a new chapter of innovation-driven development with the power of capital.
Dalton Venture's Sun Qi: Prioritize Hard-Tech Sectors That Serve National Needs, Prioritize Solving Supply Chain Security Issues | Dalton Insights
At the "2023 China Investment Annual Conference" summit, Sun Qi shared his perspectives and experience with fellow guests on the topic of *How Much Longer Is the Window for Domestic Substitution in Medical Devices?*
The Essential GP Skillset Today: Reading Policy, Reading the Macro Trend, and Getting the Timing Right | Dalton Insight
China's past economic growth was bought with high-intensity input of production factors. The only way to break through going forward is to use technology to transform production relations and shift toward high-quality development.
